Has Brandon Kimbrel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $42,775 in general payments to Brandon Kimbrel, MD across 186 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brandon Kimbrel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brandon Kimbrel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brandon Kimbrel, MD

Orthopaedic Surgery · Birmingham, ALNPI 1073042701

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (46.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Arthrex at 55.1% of the total. Reporting peaked in 2022 at $24,761 and has fallen 83.1% since, to $4,181 in 2025. Among orthopaedic surgery clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$42,775in general payments, 2019–2025

Across 186 payments — averaging $229.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$24K
Smith+Nephew$6K
ALON Medical Technology$4K
Stryker$3K
Zimmer Biomet$2K
Medical Device Business Services, Inc.$2K
plus $2K from 8 others

What the payments were for

Grants$20,00047%
Travel & lodging$7,46317%
Food & beverage$6,05114%
Education$9,26222%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	58	$23,567
Smith+Nephew	3	$6,215
ALON Medical Technology	33	$4,281
Stryker	49	$2,939
Zimmer Biomet	21	$2,003
Medical Device Business Services, Inc.	7	$1,800
Prime Surgical, LLC	2	$1,214
Johnson & Johnson	6	$510
Vericel Corporation	1	$100
Bioventus LLC	1	$52
Linvatec Corporation	1	$34
Ferring Pharmaceuticals Inc.	2	$30
Mimedx Group, Inc.	1	$16
Next Science LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$1,438
Persona$890
REUNION$535
T2$535
GAMMA$535
ADAPT$535
Avenir$459
Healicoil$208
FLEXIBLE GUIDE PIN (STRYKER ACL VERSITOMIC)$161
Persona Revision$134
SHOULDER IMPLANTS BICEPS REPAIR FIBERTAK$134
SHOULDER IMPLANTS FIBERTAK KNOTLESS$134
INSPACE$127
CONDUIT$119
ZIPSEAL 24 SURGICAL SKIN CLOSURE KIT$116
N/A$104
Double Pump RF$104
Bioinductive Implant with Arthroscopic Delivery System - Medium$104
MACI$100

How this compares

$42,775 in reported general payments places this provider in the 90th percentile of 319 orthopaedic surgery providers in Alabama.

See all orthopaedic surgery providers in Alabama →

Medicare billing

Part B allowed, 2024

$106,800

Medicare patients

244

Services billed

1,597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	114	$363
Celecoxib	22	$280
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	26	$276
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$125
Naproxen	16	$99
Ondansetron OdtOndansetron	13	$72
Tramadol Hcl	16	$45
Ondansetron Hcl	12	$37

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Birmingham

Jeffrey DugasBirmingham$11.5M
Benton EmblomBirmingham$3M
Herrick SiegelBirmingham$1.2M
Kenneth MooreBirmingham$342K
Joseph SherrillBirmingham$221K
Jonathan QuadeBirmingham$217K
Ginger BryantBirmingham$209K
Marcus RothermichBirmingham$207K
Daniel KimBirmingham$147K
Eugene BrabstonBirmingham$117K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →